Siloxane Nanoprobes for Labeling and Dual Modality Functional Imaging of Neural Stem Cells

Caroline P. Addington, Alex Cusick, Rohini Vidya Shankar, Shubhangi Agarwal, Sarah Stabenfeldt, Vikram Kodibagkar

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Cell therapy represents a promising therapeutic for a myriad of medical conditions, including cancer, traumatic brain injury, and cardiovascular disease among others. A thorough understanding of the efficacy and cellular dynamics of these therapies necessitates the ability to non-invasively track cells in vivo. Magnetic resonance imaging (MRI) provides a platform to track cells as a non-invasive modality with superior resolution and soft tissue contrast. We recently reported a new nanoprobe platform for cell labeling and imaging using fluorophore doped siloxane core nanoemulsions as dual modality (1H MRI/Fluorescence), dual-functional (oximetry/detection) nanoprobes. Here, we successfully demonstrate the labeling, dual-modality imaging, and oximetry of neural progenitor/stem cells (NPSCs) in vitro using this platform. Labeling at a concentration of 10 μL/104 cells with a 40%v/v polydimethylsiloxane core nanoemulsion, doped with rhodamine, had minimal effect on viability, no effect on migration, proliferation and differentiation of NPSCs and allowed for unambiguous visualization of labeled NPSCs by 1H MR and fluorescence and local pO2 reporting by labeled NPSCs. This new approach for cell labeling with a positive contrast 1H MR probe has the potential to improve mechanistic knowledge of current therapies, and guide the design of future cell therapies due to its clinical translatability.

Original languageEnglish (US)
Pages (from-to)816-827
Number of pages12
JournalAnnals of Biomedical Engineering
Volume44
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Nanoprobes
Stem cells
Labeling
Imaging techniques
Magnetic resonance imaging
Fluorescence
Fluorophores
Polydimethylsiloxane
Brain
Visualization
Tissue

Keywords

  • Cell-labeling
  • Dual-modality imaging
  • Fluorescence
  • MR oximetry
  • Nanoemulsions
  • Neural progenitor/stem cells
  • Polydimethylsiloxane
  • Rhodamine

ASJC Scopus subject areas

  • Biomedical Engineering

Cite this

Siloxane Nanoprobes for Labeling and Dual Modality Functional Imaging of Neural Stem Cells. / Addington, Caroline P.; Cusick, Alex; Shankar, Rohini Vidya; Agarwal, Shubhangi; Stabenfeldt, Sarah; Kodibagkar, Vikram.

In: Annals of Biomedical Engineering, Vol. 44, No. 3, 01.03.2016, p. 816-827.

Research output: Contribution to journalArticle

Addington, Caroline P. ; Cusick, Alex ; Shankar, Rohini Vidya ; Agarwal, Shubhangi ; Stabenfeldt, Sarah ; Kodibagkar, Vikram. / Siloxane Nanoprobes for Labeling and Dual Modality Functional Imaging of Neural Stem Cells. In: Annals of Biomedical Engineering. 2016 ; Vol. 44, No. 3. pp. 816-827.
@article{b98ba6c59ad14a7d9a3543970a5825da,
title = "Siloxane Nanoprobes for Labeling and Dual Modality Functional Imaging of Neural Stem Cells",
abstract = "Cell therapy represents a promising therapeutic for a myriad of medical conditions, including cancer, traumatic brain injury, and cardiovascular disease among others. A thorough understanding of the efficacy and cellular dynamics of these therapies necessitates the ability to non-invasively track cells in vivo. Magnetic resonance imaging (MRI) provides a platform to track cells as a non-invasive modality with superior resolution and soft tissue contrast. We recently reported a new nanoprobe platform for cell labeling and imaging using fluorophore doped siloxane core nanoemulsions as dual modality (1H MRI/Fluorescence), dual-functional (oximetry/detection) nanoprobes. Here, we successfully demonstrate the labeling, dual-modality imaging, and oximetry of neural progenitor/stem cells (NPSCs) in vitro using this platform. Labeling at a concentration of 10 μL/104 cells with a 40{\%}v/v polydimethylsiloxane core nanoemulsion, doped with rhodamine, had minimal effect on viability, no effect on migration, proliferation and differentiation of NPSCs and allowed for unambiguous visualization of labeled NPSCs by 1H MR and fluorescence and local pO2 reporting by labeled NPSCs. This new approach for cell labeling with a positive contrast 1H MR probe has the potential to improve mechanistic knowledge of current therapies, and guide the design of future cell therapies due to its clinical translatability.",
keywords = "Cell-labeling, Dual-modality imaging, Fluorescence, MR oximetry, Nanoemulsions, Neural progenitor/stem cells, Polydimethylsiloxane, Rhodamine",
author = "Addington, {Caroline P.} and Alex Cusick and Shankar, {Rohini Vidya} and Shubhangi Agarwal and Sarah Stabenfeldt and Vikram Kodibagkar",
year = "2016",
month = "3",
day = "1",
doi = "10.1007/s10439-015-1514-1",
language = "English (US)",
volume = "44",
pages = "816--827",
journal = "Annals of Biomedical Engineering",
issn = "0090-6964",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Siloxane Nanoprobes for Labeling and Dual Modality Functional Imaging of Neural Stem Cells

AU - Addington, Caroline P.

AU - Cusick, Alex

AU - Shankar, Rohini Vidya

AU - Agarwal, Shubhangi

AU - Stabenfeldt, Sarah

AU - Kodibagkar, Vikram

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Cell therapy represents a promising therapeutic for a myriad of medical conditions, including cancer, traumatic brain injury, and cardiovascular disease among others. A thorough understanding of the efficacy and cellular dynamics of these therapies necessitates the ability to non-invasively track cells in vivo. Magnetic resonance imaging (MRI) provides a platform to track cells as a non-invasive modality with superior resolution and soft tissue contrast. We recently reported a new nanoprobe platform for cell labeling and imaging using fluorophore doped siloxane core nanoemulsions as dual modality (1H MRI/Fluorescence), dual-functional (oximetry/detection) nanoprobes. Here, we successfully demonstrate the labeling, dual-modality imaging, and oximetry of neural progenitor/stem cells (NPSCs) in vitro using this platform. Labeling at a concentration of 10 μL/104 cells with a 40%v/v polydimethylsiloxane core nanoemulsion, doped with rhodamine, had minimal effect on viability, no effect on migration, proliferation and differentiation of NPSCs and allowed for unambiguous visualization of labeled NPSCs by 1H MR and fluorescence and local pO2 reporting by labeled NPSCs. This new approach for cell labeling with a positive contrast 1H MR probe has the potential to improve mechanistic knowledge of current therapies, and guide the design of future cell therapies due to its clinical translatability.

AB - Cell therapy represents a promising therapeutic for a myriad of medical conditions, including cancer, traumatic brain injury, and cardiovascular disease among others. A thorough understanding of the efficacy and cellular dynamics of these therapies necessitates the ability to non-invasively track cells in vivo. Magnetic resonance imaging (MRI) provides a platform to track cells as a non-invasive modality with superior resolution and soft tissue contrast. We recently reported a new nanoprobe platform for cell labeling and imaging using fluorophore doped siloxane core nanoemulsions as dual modality (1H MRI/Fluorescence), dual-functional (oximetry/detection) nanoprobes. Here, we successfully demonstrate the labeling, dual-modality imaging, and oximetry of neural progenitor/stem cells (NPSCs) in vitro using this platform. Labeling at a concentration of 10 μL/104 cells with a 40%v/v polydimethylsiloxane core nanoemulsion, doped with rhodamine, had minimal effect on viability, no effect on migration, proliferation and differentiation of NPSCs and allowed for unambiguous visualization of labeled NPSCs by 1H MR and fluorescence and local pO2 reporting by labeled NPSCs. This new approach for cell labeling with a positive contrast 1H MR probe has the potential to improve mechanistic knowledge of current therapies, and guide the design of future cell therapies due to its clinical translatability.

KW - Cell-labeling

KW - Dual-modality imaging

KW - Fluorescence

KW - MR oximetry

KW - Nanoemulsions

KW - Neural progenitor/stem cells

KW - Polydimethylsiloxane

KW - Rhodamine

UR - http://www.scopus.com/inward/record.url?scp=84961165391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961165391&partnerID=8YFLogxK

U2 - 10.1007/s10439-015-1514-1

DO - 10.1007/s10439-015-1514-1

M3 - Article

VL - 44

SP - 816

EP - 827

JO - Annals of Biomedical Engineering

JF - Annals of Biomedical Engineering

SN - 0090-6964

IS - 3

ER -